Dose finding Phase 2a Study of Inecalcitol in Combination with Standard Docetaxel Prednisone Regimen in Hormone-Refractory Prostate Cancer.
Phase of Trial: Phase II
Latest Information Update: 03 Jul 2012
At a glance
- Drugs Inecalcitol (Primary) ; Docetaxel; Prednisone
- Indications Prostate cancer
- Focus Adverse reactions
- 25 Jul 2011 New trial record
- 31 May 2011 Final results were reported at the Annual Meeting of the American Society of Clinical Oncology (ASCO-2011).
- 31 May 2011 Status changed from recruiting to completed.